迷幻药物医学化的知识差距:临床前和神经成像机制
Drummond E-Wen McCulloch1, Juan Pablo Lopez2, Christina Dalla3
1Neurobiology Research Unit, Rigshospitalet, and University of Copenhagen, Copenhagen, Denmark.
Neuroscience applied
|July 14, 2025
概括
针对色素2A受体 (5-HT2AR) 的psilocybin和LSD等迷幻药物正在为大脑疾病进行研究. 专家们在临床前和临床环境中发现了它们的机制,作用和最佳使用方面的知识差距.
科学领域:
- 神经科学是一个神经科学.
- 心理药理学 心理药理学
- 翻译医学是一种翻译医学.
背景情况:
- 经典的迷幻药物,包括psilocybin和LSD,与血清素2A受体 (5-HT2AR) 相互作用.
- 这些化合物正在进行强烈的研究,以寻找在各种脑部疾病中潜在的治疗应用.
- 最近的进展凸显出需要更深入地了解它们的神经生物学基础的需要.
研究的目的:
- 解决关于迷幻化合物的作用机制的关键知识差距.
- 巩固当前的理解,并确定未来的心理学科学研究方向.
- 将临床前模型的发现与临床神经成像数据相结合.
主要方法:
- 在ECNP"新前沿"会议 (2023年3月) 的专家共识会议上.
- 对评估急性和持续性迷幻效应的临床前模型的审查.
- 讨论临床神经成像技术来评估迷幻影响.
主要成果:
- 确定了关键的研究重点,包括行为模型开发和剂量优化.
- 强调研究分子机制,性别差异和神经递质释放的必要性.
- 强调研究对功能性大脑活动的急性和长期影响的重要性.
结论:
- 需要进一步的研究才能充分阐明迷幻药作用的复杂机制.
- 标准化模型和方法对于推进迷幻研究至关重要.
- 了解性别差异和长期影响对于临床翻译至关重要.
相关概念视频
Hallucinogens and Psychedelics
287
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
287
CNS Stimulants: Psychedelic Agents
252
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
252
An Overview of Psychoactive Drugs
303
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
303
Altered States of Awareness
483
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
483
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
993
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
993
Preclinical Development: Overview
4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K


